Market revenue in 2023 | USD 15.9 million |
Market revenue in 2030 | USD 24.4 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 55.35% in 2023. Horizon Databook has segmented the Middle East & Africa bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The MEA region is expected to witness a notable increase in respiratory conditions, including asthma, COPD, and lung cancer. This surge in disease prevalence necessitates effective diagnostic tools, including bronchial biopsy devices, to facilitate early detection and treatment.
In addition, there is a growing emphasis on public health campaigns aimed at increasing awareness of respiratory diseases and the importance of regular health check-ups. These initiatives are expected to drive the demand for bronchial biopsy procedures as more patients seek early diagnosis and treatment options.
Furthermore, innovations in bronchial biopsy devices, such as EBUS and robotic-assisted systems, are enhancing the accuracy & safety of procedures. These advancements are making bronchial biopsies less invasive and more efficient, likely increasing their adoption in clinical settings across MEA. However, inconsistent reimbursement policies across different countries in the MEA might impede the adoption of bronchial biopsy procedures.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa bronchial biopsy devices market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account